ValuentumAd

Official PayPal Seal
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Latest Valuentum Commentary

Jun 7, 2019
Exact Sciences: Great Company But Most of the Upside Is Behind It
Image Source: Exact Sciences Corp -- IR Presentation. Exact Sciences operates as a molecular diagnostics company built around its Cologuard offering, which was approved by the US FDA in August 2014. While Exact Sciences stock has performed very well since 2016, the risk-reward trade off isn’t great as things stand today now that shares have zoomed from the single-digits in 2016 to roughly $105 per share as of this writing.
May 8, 2019
Allergan's Peculiar Non-GAAP Reporting, Wendy's Free Cash Flow, More Reports
In alphabetical order by ticker symbol: AGN, EA, ENR, LYFT MYL, PZZA, S, WEN.
Apr 2, 2019
Lyft Takes a Fall, S-1 Reads Like Business School Homework
Image Source: Lyft S-1Reminiscences of the dot-com boom came back to the markets with the over-hyped initial public offering of Lyft, a stock that continues to get shellacked as its first days as a publicly-traded enterprise. Those that know Valuentum know that we wouldn’t touch such investments with a 10-foot pole. The company lost $43 per share in 2018.
Oct 23, 2016
PayPal: The Way of the Future
Image Source: PayPal. Paying for services online is the way of the future, and PayPal remains an interesting idea to play this theme. Its powerful network effect creates considerable barriers to entry.


Latest News and Media
The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.